UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.

UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.

Oncotarget (2017-11-09)

Corina T Madreiter-Sokolowski, Balázs Győrffy, Christiane Klec, Armin A Sokolowski, Rene Rost, Markus Waldeck-Weiermair, Roland Malli, Wolfgang F Graier

PMID29113301

ABSTRACT

Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca

MATERIALS

Product Number

Brand

Product Description

EHU007971

Sigma-Aldrich

MISSION^® esiRNA, targeting human UCP2